期刊文献+

血清骨保护素、sRANKL水平与急性冠脉综合征关系的临床研究

Correlation of serum osteoprotegerin,sRANKL level with acute coronary artery syndrome
原文传递
导出
摘要 目的探讨血清骨保护素(OPG)水平、sRANKL水平与急性冠脉综合征(ACS)的关系。方法选取急性冠脉综合征患者50例,不稳定性心绞痛患者45例,32例冠脉造影正常无冠心病者为对照组。采用全自动生化仪测定LDL-C、hs-CRP等指标水平。采用ELISA法检测血清OPG、sRANKL水平,每例患者均行冠脉造影,并对冠脉进行Gensini评分。结果 ACS组患者血清OPG水平显著高于对照组及不稳定性心绞痛组(P<0.01),而血清sRANKL水平显著低于其他两组(P<0.01)。ACS组血清OPG水平与hs-CRP水平、Gensini评分成正相关(P<0.05),而sRANKL水平与hs-CRP水平、Gensini评分成负相关(P<0.01)。结论血清OPG水平升高、sRNAKL水平降低与ACS的冠状动脉病变严重程度密切相关,检测血清中两者的水平对ACS的辅助诊断、疗效观察及预后判断具有重要价值。 Objective To measure the serum levels of osteoprotegerin(OPG) and sRANKL and explore the correlation of acute coronary syndrome(ACS) and concentrations of OPG and sRANKL.Methods 50 patients of ACS,45 patients with stable angina pectoris(UAP) and 32 patients without coronary heart disease were included for the study.The concentrations of OPG and sRANKL were detected by enzyme-linked immunosorbent assay(ELISA).High sensitive C reactive protein(hsCRP) and low density lipoprotein cholesterol(LDL-C) were analyzed by Automatic biochemical analyzer.All the objects were underwent coronary angiography and the Gensini score.Results The levels of OPG were significantly higher in ACS group than those of UAP and control group(P〈0.01).The levels of sRANKL were obviously decreased in ACS group than those of UAP and control group(P〈0.01).The level of OPG in ACS group was positively correlated with the level of hs-CRP and Gensini score(P〈0.01).The level of sRANKL was negatively correlated with Gensini score and hs-CRP(P〈0.01).Neither of OPG and sRANKL was correlated with the concentration of LDL-C in plasma(P〈0.05).Conclusion Plasma levels of OPG and sRANKL are closely related to ACS,which can be used as important indicators for diagnosis and treatment in ACS.
出处 《热带医学杂志》 CAS 2011年第11期1283-1285,共3页 Journal of Tropical Medicine
基金 深圳市科技计划项目(200903245)
关键词 急性冠脉综合征 骨保护素 核因子ΚB受体活化因子配体 acute coronary syndrome osteoprotegerin ligand of receptor activator of NF-кB
  • 相关文献

参考文献12

  • 1Browner WS, Lui LY, Cummings SR. Association of serum osteoprotegerin levels with diabetes, stroke, bonedensity, fraetures ,and mortality in elderly women [J].J Clin Endocrinol Metab, 2001,86 (2) : 631-637.
  • 2王丽蕊,李凌,赵晓燕,陈雅丽,董文杰,朱慎慎.血清骨保护素和可溶性核因子κB受体活化因子配体水平与急性冠状动脉综合征的相关性研究[J].临床心血管病杂志,2010,26(9):705-707. 被引量:6
  • 3王丽蕊,李凌,陈雅丽,董文杰,车丽玲,肖莉丽.冠心病患者血清OPG、sRANKL变化与冠脉病变程度的关系[J].山东医药,2010,50(5):7-8. 被引量:4
  • 4Hansson GK, Libby P, Schonbeck U, et al. Innate and adaptive immunity in the pathogenesis of atherosclerosis [J].Cire Res, 2002,91 (4) : 281-291.
  • 5Zhang J, Fu M, Myles D, et al. PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways [ J ].FEBS Lett, 2002,521 ( 1-3 ) : 180-184.
  • 6Fu M,Zhang J, Lin Y,et al. Activation of peroxisome proliferator- activated receptor gamma inhibits osteoprotegerin gene expression in human aortic smooth muscle cells [ J ]. Biochem Biophys Res Commun, 2002,294 ( 3 ) : 597-601.
  • 7Schoppet M, Sattler AM, Schaefer JR, et al. Michael schoppet. Increased osteoprotegerin serum levels in men with coronary artery disease [ J ]. J Clin Endocrinol Metab, 2003, 88 (3) : 1024-1028.
  • 8罗助荣,张克己,郑磊磊,徐高阳,林毅,郑卫星,盖晓波.非ST段抬高急性冠脉综合征患者血清骨保护素和脑钠肽水平与冠状动脉病变程度相关性研究[J].中国全科医学,2010,13(35):3961-3963. 被引量:8
  • 9AvignonA, Sultan A, Piot C, et al.Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients [ J ].Diabetes Care, 2005,28 (9) : 2176-2180.
  • 10Jono S, Shioi A, IkariY, et al. Vascular calcification in chronic kidney disease[J]. J Bone Miner Metab,2006, 24(2) : 176-181.

二级参考文献23

  • 1Browner WS, Lui LY, Cummings SR. Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women[ J]. J Clin Endocrinol Metab, 2001,86 (2) :631-637.
  • 2Jono S, Ikari Y, Shioi A, et al. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease [J]. Circulation, 2002,106(10) :1192-1194.
  • 3Anand DV, Lahiri A, Lim E, et al. The relationship between plasma osteo protegerin levels and coronary artery calcification uncomplicated type 2 diabetic subjects [ J ]. J Am Coll Cardiol, 2006,47 (9) :1850-1857.
  • 4Schoppet M, Schaefer JR, Hofbauer LC, et al. Low serum levels of soluble RANK ligand are associated with the presence of coronary artery disease in men[ J]. Circulation, 2003,107 ( 11 ) :76.
  • 5KAZAMA J J.Osteoprotegerin and bone mineral metabolism in renal failure[J].Curr Opin Nephrol Hypertens,2004,13:411-415.
  • 6SANDBERG W J,YNDESTAD A,IE E,et al.Enhanced T-cell expression of RANK ligand in acute coronary syndrome:possible role in plaque destabilization[J].Arterioscler Thromb Vasc Biol,2006,26:857-863.
  • 7ZHANG J,FU M,MYLES D,et al.PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways[J].FEBS Lett,2002,521:180-184.
  • 8MORONY S,TINTUT Y,ZHANG Z,et al.Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice[J].Circulation,2008,117:411-420.
  • 9MOSHEIMER B A,KANEIDER N C,FEISTRITZER C,et al.Expression and function of RANK in human monocyte chemotaxis[J].Arthritis Rheum,2004,50:2309-2316.
  • 10CRISAFULLI A,MICARI A,ALTAVILLA D,et al.Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction[J].Clin Sci (Lond),2005,109:389-395.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部